Cargando…

Simultaneous LC-MS/MS-Based Quantification of Free 3-Nitro-l-tyrosine, 3-Chloro-l-tyrosine, and 3-Bromo-l-tyrosine in Plasma of Colorectal Cancer Patients during Early Postoperative Period

Quantification with satisfactory specificity and sensitivity of free 3-Nitro-l-tyrosine (3-NT), 3-Chloro-l-tyrosine (3-CT), and 3-Bromo-l-tyrosine (3-BT) in biological samples as potential inflammation, oxidative stress, and cancer biomarkers is analytically challenging. We aimed at developing a liq...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleszar, Mariusz G., Fortuna, Paulina, Zawadzki, Marek, Kosyk, Bogna, Krzystek-Korpacka, Małgorzata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663926/
https://www.ncbi.nlm.nih.gov/pubmed/33167555
http://dx.doi.org/10.3390/molecules25215158
_version_ 1783609739588927488
author Fleszar, Mariusz G.
Fortuna, Paulina
Zawadzki, Marek
Kosyk, Bogna
Krzystek-Korpacka, Małgorzata
author_facet Fleszar, Mariusz G.
Fortuna, Paulina
Zawadzki, Marek
Kosyk, Bogna
Krzystek-Korpacka, Małgorzata
author_sort Fleszar, Mariusz G.
collection PubMed
description Quantification with satisfactory specificity and sensitivity of free 3-Nitro-l-tyrosine (3-NT), 3-Chloro-l-tyrosine (3-CT), and 3-Bromo-l-tyrosine (3-BT) in biological samples as potential inflammation, oxidative stress, and cancer biomarkers is analytically challenging. We aimed at developing a liquid chromatography–tandem mass spectrometry (LC-MS/MS)-based method for their simultaneous analysis without an extract purification step by solid-phase extraction. Validation of the developed method yielded the following limits of detection (LOD) and quantification (LOQ) for 3-NT, 3-BT, and 3-CT: 0.030, 0.026, 0.030 ng/mL (LODs) and 0.100, 0.096, 0.098 ng/mL (LOQs). Coefficients of variation for all metabolites and tested concentrations were <10% and accuracy was within 95–105%. Method applicability was tested on colorectal cancer patients during the perioperative period. All metabolites were significantly higher in cancer patients than healthy controls. The 3-NT was significantly lower in advanced cancer and 3-BT showed a similar tendency. Dynamics of 3-BT in the early postoperative period were affected by type of surgery and presence of surgical site infections. In conclusion, a sensitive and specific LC-MS/MS method for simultaneous quantification of free 3-NT, 3-BT, and 3-CT in human plasma has been developed.
format Online
Article
Text
id pubmed-7663926
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76639262020-11-14 Simultaneous LC-MS/MS-Based Quantification of Free 3-Nitro-l-tyrosine, 3-Chloro-l-tyrosine, and 3-Bromo-l-tyrosine in Plasma of Colorectal Cancer Patients during Early Postoperative Period Fleszar, Mariusz G. Fortuna, Paulina Zawadzki, Marek Kosyk, Bogna Krzystek-Korpacka, Małgorzata Molecules Article Quantification with satisfactory specificity and sensitivity of free 3-Nitro-l-tyrosine (3-NT), 3-Chloro-l-tyrosine (3-CT), and 3-Bromo-l-tyrosine (3-BT) in biological samples as potential inflammation, oxidative stress, and cancer biomarkers is analytically challenging. We aimed at developing a liquid chromatography–tandem mass spectrometry (LC-MS/MS)-based method for their simultaneous analysis without an extract purification step by solid-phase extraction. Validation of the developed method yielded the following limits of detection (LOD) and quantification (LOQ) for 3-NT, 3-BT, and 3-CT: 0.030, 0.026, 0.030 ng/mL (LODs) and 0.100, 0.096, 0.098 ng/mL (LOQs). Coefficients of variation for all metabolites and tested concentrations were <10% and accuracy was within 95–105%. Method applicability was tested on colorectal cancer patients during the perioperative period. All metabolites were significantly higher in cancer patients than healthy controls. The 3-NT was significantly lower in advanced cancer and 3-BT showed a similar tendency. Dynamics of 3-BT in the early postoperative period were affected by type of surgery and presence of surgical site infections. In conclusion, a sensitive and specific LC-MS/MS method for simultaneous quantification of free 3-NT, 3-BT, and 3-CT in human plasma has been developed. MDPI 2020-11-05 /pmc/articles/PMC7663926/ /pubmed/33167555 http://dx.doi.org/10.3390/molecules25215158 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fleszar, Mariusz G.
Fortuna, Paulina
Zawadzki, Marek
Kosyk, Bogna
Krzystek-Korpacka, Małgorzata
Simultaneous LC-MS/MS-Based Quantification of Free 3-Nitro-l-tyrosine, 3-Chloro-l-tyrosine, and 3-Bromo-l-tyrosine in Plasma of Colorectal Cancer Patients during Early Postoperative Period
title Simultaneous LC-MS/MS-Based Quantification of Free 3-Nitro-l-tyrosine, 3-Chloro-l-tyrosine, and 3-Bromo-l-tyrosine in Plasma of Colorectal Cancer Patients during Early Postoperative Period
title_full Simultaneous LC-MS/MS-Based Quantification of Free 3-Nitro-l-tyrosine, 3-Chloro-l-tyrosine, and 3-Bromo-l-tyrosine in Plasma of Colorectal Cancer Patients during Early Postoperative Period
title_fullStr Simultaneous LC-MS/MS-Based Quantification of Free 3-Nitro-l-tyrosine, 3-Chloro-l-tyrosine, and 3-Bromo-l-tyrosine in Plasma of Colorectal Cancer Patients during Early Postoperative Period
title_full_unstemmed Simultaneous LC-MS/MS-Based Quantification of Free 3-Nitro-l-tyrosine, 3-Chloro-l-tyrosine, and 3-Bromo-l-tyrosine in Plasma of Colorectal Cancer Patients during Early Postoperative Period
title_short Simultaneous LC-MS/MS-Based Quantification of Free 3-Nitro-l-tyrosine, 3-Chloro-l-tyrosine, and 3-Bromo-l-tyrosine in Plasma of Colorectal Cancer Patients during Early Postoperative Period
title_sort simultaneous lc-ms/ms-based quantification of free 3-nitro-l-tyrosine, 3-chloro-l-tyrosine, and 3-bromo-l-tyrosine in plasma of colorectal cancer patients during early postoperative period
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7663926/
https://www.ncbi.nlm.nih.gov/pubmed/33167555
http://dx.doi.org/10.3390/molecules25215158
work_keys_str_mv AT fleszarmariuszg simultaneouslcmsmsbasedquantificationoffree3nitroltyrosine3chloroltyrosineand3bromoltyrosineinplasmaofcolorectalcancerpatientsduringearlypostoperativeperiod
AT fortunapaulina simultaneouslcmsmsbasedquantificationoffree3nitroltyrosine3chloroltyrosineand3bromoltyrosineinplasmaofcolorectalcancerpatientsduringearlypostoperativeperiod
AT zawadzkimarek simultaneouslcmsmsbasedquantificationoffree3nitroltyrosine3chloroltyrosineand3bromoltyrosineinplasmaofcolorectalcancerpatientsduringearlypostoperativeperiod
AT kosykbogna simultaneouslcmsmsbasedquantificationoffree3nitroltyrosine3chloroltyrosineand3bromoltyrosineinplasmaofcolorectalcancerpatientsduringearlypostoperativeperiod
AT krzystekkorpackamałgorzata simultaneouslcmsmsbasedquantificationoffree3nitroltyrosine3chloroltyrosineand3bromoltyrosineinplasmaofcolorectalcancerpatientsduringearlypostoperativeperiod